MedTrace Logo

Orebro Musculoskeletal Screening Questionnaire-12

NCT04723615 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 319

Last updated 2022-01-20

No results posted yet for this study

Summary

The research is a study with methodological design. The validity, reliability and practicality of the Örebro Musculoskeletal System Screening Questionnaire-12 will be investigated. In this context, a questionnaire will be applied to the participants to take part in the study after the translation process is completed.

Conditions

  • Musculoskeletal Injury

Interventions

OTHER

Orebro Musculoskeletal Screening Questionnaire-12

It is a 12-item self-report questionnaire that aims to estimate the severity of the problem, functional impairment, reporting status, cost and recovery time in musculoskeletal problems.

OTHER

Visual Analog Scale

A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.

OTHER

The Tampa Scale of Kinesiophobia

The Tampa Scale of Kinesiophobia that was developed in 1990 is a 17 item scale originally developed to measure the fear of movement related to chronic lower back pain.

OTHER

Short Form-12 (SF-12)

The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.

Sponsors & Collaborators

  • Afyonkarahisar Health Sciences University

    lead OTHER

Principal Investigators

  • EMEL TAŞVURAN HORATA · Afyonkarahisar Health Science University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2023-12-18
Completion
2024-12-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04723615 on ClinicalTrials.gov